News Features Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI? L.A. McKeown December 02, 2022
News Daily News Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study Michael O'Riordan November 18, 2022
News Conference News Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices L.A. McKeown November 18, 2022
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News VIVA 2022 ‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups L.A. McKeown November 04, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2022 Shelley Wood October 31, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2022 Shelley Wood October 03, 2022
Presentation TCT 2022 TCT 647: Single Pedal access for revascularization of critical limb ischemia: A challenging case of a unilateral pedal-to-pedal intervention Presenter: Mohammed Salih September 19, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Daily News IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document L.A. McKeown August 05, 2022
News Daily News Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients L.A. McKeown June 29, 2022
News Daily News COVID-19 Had Broad Global Effects on CV Care, Review Affirms Todd Neale June 02, 2022
News Daily News Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy L.A. McKeown June 01, 2022
News Conference News SCAI 2022 Cocaine History? For Black Patients It Means Less Chance of Revascularization L.A. McKeown May 26, 2022
News Daily News Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions L.A. McKeown May 06, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2022 Shelley Wood May 02, 2022
News Daily News SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement L.A. McKeown April 27, 2022